Ilyda

Ilyda CROIC

The Cash Return on Invested Capital (CROIC) of Ilyda (ILYDA.AT) as of Nov 16, 2026 is 27.80 %. In the previous year, Cash Return on Invested Capital (CROIC) was 8.73 % — a change of 218.52% (higher).

CROIC

27.80 %

YoY

218.52%

Last updated:

Cash Return on Invested Capital (CROIC) of Ilyda is 2025 27.80 % . Cash Return on Invested Capital (CROIC) of Ilyda was 2024 8.73 % . It decreases by 218.52% higher compared to the previous year.

The Ilyda CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
8.49 EUR
Jan 1, 2019
-2.65 EUR
Jan 1, 2020
0.76 EUR
Jan 1, 2021
9.75 EUR
Jan 1, 2022
19.85 EUR
Jan 1, 2023
27.27 EUR
Jan 1, 2024
8.73 EUR
Jan 1, 2025
27.80 EUR
The Ilyda CROIC history
YEARCROICYoY
27.80 %+218.52%
8.73 %-67.99%
27.27 %+37.39%
19.85 %+103.58%
9.75 %+1,188.42%
0.76 %-128.55%
-2.65 %-131.22%
8.49 %+1,471.00%
0.54 %-40.24%
0.90 %-90.53%
9.55 %-290.62%
-5.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ilyda Stock analysis

What does Ilyda do? Ilyda SA develops software solutions including ERP systems and specialized vertical market applications. The company offers MegaTron ERP for business resource management, MegaTron Pharma for pharmacy warehouse management, VitaCard for consumer privileges, and payroll and personnel management software. Ilyda SA provides customer training, after-sales support, and maintenance services for its products. Enterprise clients such as retail chains, pharmacies, financial institutions, and public sector organizations purchase these software solutions and services. The company targets retail chains with point-of-sale programs, pharmacies using MegaTron Pharma, and financial institutions requiring tailored software. Public sector entities and educational institutions also buy Ilyda SA's customized applications. Ilyda SA generates revenue through the sale of its software products and associated support services for these specific market segments. MegaTron ERP, MegaTron Pharma, VitaCard, and payroll management systems are the core products sold to enterprise customers. Retail chains, pharmacies, banks, and public sector organizations represent the primary buyer segments. The company's revenue model combines product sales with ongoing service contracts for training and maintenance. Ilyda is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ilyda stock

Cash Return on Invested Capital (CROIC) of Ilyda is 27.80 % in 2025.

Cash Return on Invested Capital (CROIC) of Ilyda changed from 8.73 % to 27.80 %, representing a 218.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Ilyda since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Ilyda with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ilyda

All Key Metrics — Ilyda